• Decrease font size
  • Reset font size to default
  • Increase font size
research.jpg

ECG Core Lab

Attention: open in a new window. PrintE-mail

CPC is committed to cardiovascular safety in new drug development by providing timely, rigorous, high-quality interpretation and analysis of study-related ECG variables.  Our capabilities as an ECG Core Lab include:

  • Utilization of state-of-the-art Mortara E-Scribe, H-Scribe and GE Muse systems to support ICH-E14 concordant analysis of ECG data
  • Timely analysis and interpretation of digital 10-second 12-lead ECG strips
  • Expert study reports for thorough QT and safety trials
  • 21 CFR Part 11 compliant data acquisition and processing
  • Quarterly or study-specific inter- and intra-reader variability (IIRV) reports
  • Rigorous QA/QC processes
  • Continuous interpreting cardiologist training program
  • Full service biostatistical and data management capabilities facilitating integrated and timely analysis of clinical, pharmacokinetic, and ECG data
  • Electronic submission of XML files to the FDA warehouse

Through an established partnership with ICON Development Solutions (Healthcare Discoveries), a state-of-the-art Phase I unit in San Antonio Texas, CPC provides seamless implementation of ECG studies from bedside to expert report and FDA ECG warehouse submission. This partnership features:

  • Instantaneous automated transmission of digital ECG data via an established, secure and dedicated connection
  • Jointly developed SOPs and cross-institutional team meetings ensure quality ECG data acquisition, processing, and enhanced workflow

For more information Contact Us